Claims
- 1. Hydroxamic acid polymers comprising hydroxamic groups and carboxylic acid groups, wherein the carboxylic acid groups constitute less than about 3 mole percent of the functional groups.
- 2. The polymers of claim 1 wherein said polymers are formed by the reaction of primary amide polymers selected from the group consisting of acrylamide and linear, branched, crosslinked and substituted derivatives thereof.
- 3. The polymers of claim 1 wherein said polymers are formed by the reaction of primary amide polymers with a compound selected from the group consisting of hydroxylamine and substituted hydroxylamines.
- 4. The polymers of claim 2 wherein said polymers are reacted with a compound selected from the group consisting of hydroxylamine and substituted hydroxylamines at a temperature between about 20° C. and 30° C.
- 5. The polymers of claim 2 wherein said polymers are formed at a pH of greater than 7.
- 6. The polymers of claim 2 wherein said polymer is crosslinked with a divinyl compound and has a water retention capacity of between about 1.0 and 20 grams water per gram of polymer.
- 7. The polymer of claim 1 wherein said polymers have a binding affinity of approximately 3 mmole iron(III) per gram of polymer.
- 8. A polymeric material having anticoagulant activity comprising hydroxamic acid polymers having less than about 3 mole percent carboxylic acid functional groups.
- 9. The polymeric material of claim 8 wherein approximately 70% or more of the functional groups are hydroxamic acid groups.
- 10. The polymeric material of claim 8 formed from acrylamide or a derivative thereof and hydroxylamine or a derivative thereof.
- 11. A polymeric material having urease inhibition activity comprising hydroxamic acid polymers having less than about 3 mole percent carboxylic acid functional groups.
- 12. The polymeric material of claim 11 wherein approximately 70% or more of the functional groups are hydroxamic acid groups.
- 13. The polymeric material of claim 11 formed from acrylamide or a derivative thereof and hydroxylamine or a derivative thereof.
- 14. A metal cheleting agent comprising hydroxamic acid polymers having less than about 3 mole percent carboxylic acid functional groups.
- 15. The metal cheleting agent of claim 14 having a binding capacity of approximately 3 mmoles metal ions.
- 16. An ion exchange resin comprising hydroxamic acid polymers having less than about 3 mole percent carboxylic acid functional groups.
- 17. The ion exchanger of claim 16 having a sodium-hydrogen exchange capacity of approximately 0.4 mmole ions/gram of polymer.
Parent Case Info
“This is a continuation of application Ser. No. 07/837,126, filed on Feb. 14, 1992, abandoned which, in turn, is a continuation of Ser. No. 07/341,317, filed Apr. 21, 1989 abandoned which, in turn, is a continuation of Ser. No. 07/019,066, filed Feb. 26, 1987 abandoned.”
BACKGROUND OF THE INVENTION
The United States government has rights in this invention by virtue of National Institute of Health grant No. GM25810.
US Referenced Citations (2)
Foreign Referenced Citations (1)
Number |
Date |
Country |
0104970 |
Apr 1984 |
EP |
Continuations (3)
|
Number |
Date |
Country |
Parent |
07/837126 |
Feb 1992 |
US |
Child |
08/219160 |
|
US |
Parent |
07/341317 |
Apr 1989 |
US |
Child |
07/837126 |
|
US |
Parent |
07/019066 |
Feb 1987 |
US |
Child |
07/341317 |
|
US |